Oral methotrexate-related lymphoproliferative disease presenting with severe osteonecrosis of the Jaw: A case report and literature review

Sachiko Furukawa, Kazunari Oobu, Masafumi Moriyama, Shintaro Kawano, Saori Sako, Jun Nosuke Hayashida, Ryota Matsubara, Ken Ichi Ogata, Tamotsu Kiyoshima, Seiji Nakamura

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Long-term methotrexate (MTX) treatment can cause MTX-related lymphoproliferative disorder (MTX-LPD). We experienced a case of MTX-LPD that was associated with severe osteonecrosis of the jaw mimicking medication-related osteonecrosis of the jaw. The patient was an 81-year-old woman with rheumatoid arthritis (RA) who was treated with MTX and bisphosphonate. After 7 years, she was referred to our department for the assessment of giant ulcer and exposure of the alveolar bone of the left maxilla. Histopathological and immunological analyses confirmed a diagnosis of MTX-LPD. At seven months after the cessation of MTX treatment, the ulcerative and necrotic lesions had markedly decreased in size. A 1-year follow-up examination showed no evidence of recurrence and good RA control.

Original languageEnglish
Pages (from-to)575-581
Number of pages7
JournalInternal Medicine
Volume57
Issue number4
DOIs
Publication statusPublished - 2018

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Fingerprint Dive into the research topics of 'Oral methotrexate-related lymphoproliferative disease presenting with severe osteonecrosis of the Jaw: A case report and literature review'. Together they form a unique fingerprint.

  • Cite this